These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 21969597)

  • 1. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination.
    Nembrini C; Stano A; Dane KY; Ballester M; van der Vlies AJ; Marsland BJ; Swartz MA; Hubbell JA
    Proc Natl Acad Sci U S A; 2011 Nov; 108(44):E989-97. PubMed ID: 21969597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.
    Wilson JT; Keller S; Manganiello MJ; Cheng C; Lee CC; Opara C; Convertine A; Stayton PS
    ACS Nano; 2013 May; 7(5):3912-25. PubMed ID: 23590591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8(+) T cell responses.
    Keller S; Wilson JT; Patilea GI; Kern HB; Convertine AJ; Stayton PS
    J Control Release; 2014 Oct; 191():24-33. PubMed ID: 24698946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled analysis of nanoparticle charge on mucosal and systemic antibody responses following pulmonary immunization.
    Fromen CA; Robbins GR; Shen TW; Kai MP; Ting JP; DeSimone JM
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):488-93. PubMed ID: 25548169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction Sensitive PEG Hydrogels for Codelivery of Antigen and Adjuvant To Induce Potent CTLs.
    Kapadia CH; Tian S; Perry JL; Luft JC; DeSimone JM
    Mol Pharm; 2016 Oct; 13(10):3381-3394. PubMed ID: 27551741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses.
    Kang S; Ahn S; Lee J; Kim JY; Choi M; Gujrati V; Kim H; Kim J; Shin EC; Jon S
    J Control Release; 2017 Jun; 256():56-67. PubMed ID: 28428066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8
    Knight FC; Gilchuk P; Kumar A; Becker KW; Sevimli S; Jacobson ME; Suryadevara N; Wang-Bishop L; Boyd KL; Crowe JE; Joyce S; Wilson JT
    ACS Nano; 2019 Oct; 13(10):10939-10960. PubMed ID: 31553872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivered antigen peptides to resident CD8α
    Wang L; Wang Z; Qin Y; Liang W
    Eur J Pharm Biopharm; 2020 Feb; 147():76-86. PubMed ID: 31887349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles.
    Stano A; Scott EA; Dane KY; Swartz MA; Hubbell JA
    Biomaterials; 2013 Jun; 34(17):4339-46. PubMed ID: 23478034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines.
    Gasper DJ; Neldner B; Plisch EH; Rustom H; Carrow E; Imai H; Kawaoka Y; Suresh M
    PLoS Pathog; 2016 Dec; 12(12):e1006064. PubMed ID: 27997610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination.
    Li AV; Moon JJ; Abraham W; Suh H; Elkhader J; Seidman MA; Yen M; Im EJ; Foley MH; Barouch DH; Irvine DJ
    Sci Transl Med; 2013 Sep; 5(204):204ra130. PubMed ID: 24068737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis.
    Ballester M; Nembrini C; Dhar N; de Titta A; de Piano C; Pasquier M; Simeoni E; van der Vlies AJ; McKinney JD; Hubbell JA; Swartz MA
    Vaccine; 2011 Sep; 29(40):6959-66. PubMed ID: 21787826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of antigen-specific CD4
    Weilhammer D; Dunkle AD; Blanchette CD; Fischer NO; Corzett M; Lehmann D; Boone T; Hoeprich P; Driks A; Rasley A
    Vaccine; 2017 Mar; 35(11):1475-1481. PubMed ID: 28214044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen delivery by alpha(2)-macroglobulin enhances the cytotoxic T lymphocyte response.
    Bowers EV; Horvath JJ; Bond JE; Cianciolo GJ; Pizzo SV
    J Leukoc Biol; 2009 Nov; 86(5):1259-68. PubMed ID: 19652028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8
    Matsuo K; Kitahata K; Kawabata F; Kamei M; Hara Y; Takamura S; Oiso N; Kawada A; Yoshie O; Nakayama T
    Front Immunol; 2018; 9():2775. PubMed ID: 30542351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes.
    Hjálmsdóttir Á; Bühler C; Vonwil V; Roveri M; Håkerud M; Wäckerle-Men Y; Gander B; Johansen P
    Mol Pharm; 2016 Feb; 13(2):320-9. PubMed ID: 26704885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
    Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
    J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation.
    Hirosue S; Kourtis IC; van der Vlies AJ; Hubbell JA; Swartz MA
    Vaccine; 2010 Nov; 28(50):7897-906. PubMed ID: 20934457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extending antigen release from particulate vaccines results in enhanced antitumor immune response.
    Kapadia CH; Tian S; Perry JL; Sailer D; Christopher Luft J; DeSimone JM
    J Control Release; 2018 Jan; 269():393-404. PubMed ID: 29146244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coupling of antigen to cholera toxin for dendritic cell vaccination promotes the induction of MHC class I-restricted cytotoxic T cells and the rejection of a cognate antigen-expressing model tumor.
    Eriksson K; Sun JB; Nordström I; Fredriksson M; Lindblad M; Li BL; Holmgren J
    Eur J Immunol; 2004 May; 34(5):1272-81. PubMed ID: 15114660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.